One more thing. If the management's performance is directly correlating with the SP then management did a wonderful job while the SP moved from $3 to $10 - teaming up with Patterson, working with Amarex and swallowing the FDA's dosage restriction without doing a parallel study in a foreign country using 4 dosages.
And now that they are finally cleaning the house all of a sudden they do an awful job? Explain that to me, especially Hulk, my dear five years shareholder. Further I'm interested to learn about the difference between price and value - to some it seems to be the same, or isn't it?
Wake up.